Literature DB >> 17849504

Determination and pharmacokinetic study of norcantharidin in human serum by HPLC-MS/MS method.

Chun-min Wei1, Rui Zhang, Ben-jie Wang, Gui-yan Yuan, Rui-chen Guo.   

Abstract

A sensitive, simple and selective high-performance liquid chromatography-tandem mass spectrometry method was developed and applied to the determination of norcantharidin concentration in human serum. Norcantharidin (NCTD) and cyclophosphamide (IS) in serum were extracted with acetone, separated on a C18 reversed-phase column, gradiently eluted with a mobile phase of acetonitrile-water containing 2 mm ammonium acetate and 0.1% formic acid (pH 3), ionized by positive ion pneumatically assisted electrospray and detected in the multi-reaction monitoring mode using precursor-->product ions of m/z 169.3-->123.1 for NCTD and 261.2-->140.2 for IS, respectively. The linear range of the calibration curve for NCTD was 2.5-50 ng/mL, with a lowest limit of quantification of 2.5 ng/mL, and the intra/inter-day RSD was less than 10%. The method was suitable for determination of low NCTD concentration in human serum after therapeutic oral doses, and has been successfully used for pharmacokinetic studies in healthy Chinese volunteers. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17849504     DOI: 10.1002/bmc.892

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  Inhibitory effects of norcantharidin against human lung cancer cell growth and migration.

Authors:  Jinling Luan; Huiying Duan; Qian Liu; Kazumi Yagasaki; Guoying Zhang
Journal:  Cytotechnology       Date:  2010-01-20       Impact factor: 2.058

2.  Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action.

Authors:  Yan Huang; Qian Liu; Kun Liu; Kazumi Yagasaki; Guoying Zhang
Journal:  Cytotechnology       Date:  2009-07-15       Impact factor: 2.058

3.  Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin αIIb β3 binding in human platelets.

Authors:  Chih-Hsuan Hsia; Wan-Jung Lu; Kuan-Hung Lin; Duen-Suey Chou; Pitchairaj Geraldine; Thanasekaran Jayakuma; Nen-Chung Chang; Joen-Rong Sheu
Journal:  J Cell Mol Med       Date:  2018-01-25       Impact factor: 5.310

4.  Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.

Authors:  Min-Chen Liu; Lin Liu; Xia-Rong Wang; Wu-Ping Shuai; Ying Hu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2016-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.